Top Industry Leaders in the Keloid Treatment Market
Avita Medical RECELL System, using autologous cell suspensions for burn and wound healing, received Japanese regulatory approval, expanding its potential reach for keloid treatment.
Revita Corporation topical gel containing hyaluronic acid and palmitoyl tripeptide-5 demonstrated positive results in a Phase 2 trial for preventing keloid scarring after earlobe piercing, opening doors for non-invasive management.
Xiamen Sinocare Medical Science & Technology Co. Phase 3 trial assessing the efficacy of a silicone gel sheet for preventing keloid recurrence after surgical wound closure is ongoing, potentially adding another tool to the arsenal.
Sensus Healthcare company focuses on silicone gel sheet technologies for scar management, actively pursuing clinical research and expanding their product portfolio to address diverse keloid treatment needs.
Mylan N.V. pharmaceutical giant acquired several keloid treatment products, including imiquimod cream, showcasing increased interest in the market's potential.
List of Keloid Treatment Key Companies in the Market
- Novartis AG
- RXi Pharmaceuticals Inc.
- Sonoma Pharmaceuticals Inc.
- Bristol-Myers Squibb Company
- Pacific World Corporation
- Valeant Pharmaceuticals International Inc.
- Revitol Corporation
- Avita Medical Limited
- Sensus Healthcare
- Perrigo Company plc